This medication is not recommended for use in children or adolescents under 14 years, as the ibuprofen dose contained in the tablet is not suitable for the recommended dosage in these patients.
Senior citizens:
If you are over 60 years old, your doctor may prescribe a lower dose than usual. If so, the dose can only be increased once your doctor has confirmed that you tolerate the medication well.
Patients with kidney and/or liver diseases:
If you have a kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Ibukern than you should:
If you have taken more Ibukern than you should, or if a child has accidentally ingested the contents of the package, consult your doctor or pharmacist immediately, the Toxicological Information Service, phone: 91 562 04 20, or go to the nearest hospital to inform yourself about the risk and ask for advice on the measures to be taken, indicating the medication and the amount ingested. It is recommended to bring the package and the medication leaflet to the healthcare professional.
The symptoms of overdose may include: stomach pain, nausea, vomiting (which may contain blood-stained mucus), indifference, drowsiness, headache, involuntary eye movements, buzzing in the ears, confusion, and muscle coordination disorders.More severe symptoms may appear, such as intestinal hemorrhage, low blood pressure, low body temperature, metabolic acidosis, seizures, kidney function impairment, coma, adult respiratory distress, and transient cessation of breathing in children (after ingesting large quantities).At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing difficulties have been reported..
If a severe intoxication has occurred, the doctor will take the necessary measures.
In case of ingestion of significant amounts, activated charcoal should be administered. Gastric lavage will be considered if significant amounts have been ingested and within 60 minutes of ingestion..
If you forget to take Ibukern:
Do not take a double dose to compensate for the missed doses.
If you forget to take your dose, take it as soon as you remember. However, if the time for the next dose is near, skip the missed dose and take the next dose at your usual time.
Like all medicines, Ibukern can cause side effects, although not everyone will experience them.
The side effects of medicines like Ibukern are more common in people over 65 years old.
The incidence of side effects is lower in short-term treatments and if the daily dose is below the maximum recommended dose.
Frequencies are established according to the following classification: very common (may affect more than 1 in 10 patients); common (may affect up to 1 in 10 patients); uncommon (may affect up to 1 in 100 patients); rare (may affect up to 1 in 1000 patients); very rare (up to 1 in 10,000 patients); frequency unknown (cannot be estimated from available data).
The following side effects have been observed:
Gastrointestinal::
The most common side effects that occur with medicines containing Ibuprofen are gastrointestinal: peptic ulcers, gastrointestinal bleeding, perforations (in some cases fatal), especially in elderly patients. Nausea, vomiting, diarrhea, flatulence, constipation, stomach pain, blood in stools, mouth ulcers, worsening of ulcerative colitis and Crohn's disease have also been observed. Less frequently, gastritis has been observed.
Other side effects are:
Uncommon: mucosal inflammation with ulcer formation in the mouth.
Rare: esophageal inflammation, esophageal stricture (esophageal stenosis), exacerbation of intestinal diverticulitis disease, non-specific hemorrhagic colitis (gastroenteritis with bloody diarrhea).
Very rare: pancreatitis.
Cardiovascular:
Medicines containing Ibuprofen may be associated with a moderate increase in the risk of suffering a heart attack ("myocardial infarction") or stroke.
Chest pain, which can be a sign of a potentially severe allergic reaction called Kounis syndrome.
Edema (fluid retention), hypertension, and heart failure have also been observed in association with treatments with Ibuprofen-like medicines.
Cutaneous:
Stop treatment with Ibukern and seek immediate medical attention if you notice any of the following symptoms:
Medicines containing Ibuprofen may be associated, in very rare cases, with severe blistering reactions such as Stevens-Johnson syndrome (widespread erosions affecting the skin and two or more mucous membranes and painful lesions with necrosis and epidermal detachment) and toxic epidermal necrolysis (erosions in mucous membranes and painful lesions with necrosis and epidermal detachment).
Other side effects are:
Common: skin rash.
Uncommon: skin redness, itching, or swelling, purpura (purple spots on the skin).
Very rare: hair loss, erythema multiforme (skin lesion), light-sensitive skin reactions, inflammation of skin blood vessels.
Exceptionally, severe skin infections and complications in soft tissue during chickenpox can occur.
Frequency unknown: generalized, red, scaly rash with bumps under the skin and blisters, mainly located in skin folds, trunk, and upper limbs, accompanied by fever at the beginning of treatment (acute generalized pustular psoriasis). Stop taking Ibukern if you experience these symptoms and seek immediate medical attention. See section 2.
Immune system:
Uncommon: transient edema in areas of the skin, mucous membranes, or sometimes in internal organs (angioedema), nasal mucosa inflammation, bronchospasm (bronchi constriction that prevents air from reaching the lungs).
Rare: severe allergic reactions (anaphylactic shock). In case of severe generalized hypersensitivity reaction, facial swelling, tongue, and laryngeal swelling, bronchospasm, asthma, tachycardia, hypotension, and shock may occur.
Very rare: joint pain and fever (lupus erythematosus).
Central nervous system:
Common: fatigue or drowsiness, headache, dizziness, or feeling unsteady.
Rare: paresthesia (numbness, tingling, burning, etc. more common in hands, feet, arms, or legs).
Very rare: aseptic meningitis. In most cases where aseptic meningitis has been reported with ibuprofen, the patient had some form of autoimmune disease (such as systemic lupus erythematosus or other collagen diseases) which was a risk factor.The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation.
Psychiatric:
Uncommon: insomnia, anxiety, restlessness.
Rare: disorientation or confusion, nervousness, irritability, depression, psychotic reaction.
Auditory:
Common: vertigo. Uncommon: ringing or buzzing in the ears.
Rare: hearing difficulty.
Visual:
Uncommon: visual disturbances.
Rare: abnormal or blurred vision.
Haematological:
Rare: decreased platelets, decreased white blood cells (may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (may manifest as difficulty breathing and pale skin), decreased granulocytes (a type of white blood cell that may predispose to infections), pancytopenia (deficiency of red and white blood cells and platelets in the blood), agranulocytosis (very large decrease in granulocytes), aplastic anemia (bone marrow insufficiency to produce different types of cells) or hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial mouth ulcers, flu-like symptoms, extreme fatigue, nasal and cutaneous bleeding.
Very rare: prolonged bleeding time.
Renal:
Based on the experience with NSAIDs in general, cases of interstitial nephritis (kidney disorder), nephrotic syndrome (characterized by protein in the urine and body swelling), and renal insufficiency (sudden loss of kidney function) cannot be ruled out.
Hepatic:
Medicines containing Ibuprofen may be associated, in rare cases, with liver damage.
Other rare side effects are: hepatitis (inflammation of the liver), liver function abnormalities, and jaundice (yellowing of the skin and eyes).
Frequency unknown: liver failure (severe deterioration of the liver).
General:
Worsening of inflammation during infectious processes.
Until now, no severe allergic reactions have been reported with Ibuprofen, although they cannot be ruled out. The manifestations of this type of reaction may be fever, skin rash, abdominal pain, severe headache, nausea, vomiting, facial swelling, tongue, and throat swelling, difficulty breathing, asthma, palpitations, hypotension, or shock.
If any of the following side effects appear, stop treatment and seek immediate medical attention:
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at your local pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Ibu kern
Appearance of the product and contents of the packaging
Ibu kern 600 mg are white, elongated, smooth, unnotched tablets with the mark 600 on one face.They are presented in PVC/Aluminum blisters in packs of 40 tablets and clinical packs of 500 tablets.
Holder of the marketing authorization
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Responsible for manufacturing
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
or
Farmalider, S.A.
C/ Aragoneses, 2, Alcobendas
28108 Madrid
Spain
or
Toll Manufacturing Services, S.L.
C/ Aragoneses, 2, Alcobendas
28108 Madrid
Spain
or
National Highway I, Km 36
San Agustín de Guadalix28750
Madrid, Spain
Last review date of this leaflet: January 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.